Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

144 CO-TRIMOXAZOLE
(1999): Oakley A, Hamilton, New Zealand (from Internet)
(observation)
Nails
Nails – loss
(2000): Canning DA, JUrol163, 1386
Other
Anaphylactoid reactions/Anaphylaxis
(1998): Bijl AM+, Clin Exp Allergy 28, 510 (trimethoprim)
(1998): Siegfried EC+, JAmAcadDermatol39, 797 (passim)
(1988): Arnold PA+, Drug Intell Clin Pharm 22, 43
(1985): Gossius G+, Scand J Infect Dis 16, 373
Death
(1995): Lewis RJ, Br J Rheumatol 34(1), 84
Hypersensitivity
(2006): Mohammedi I+, Rev Med Interne 27(6), 499
(2006): Morimoto T+, Intern Med 45(2), 101
(2001): Moran KA+, South Med J 94(3), 350 (‘sepsis-like’)
(2000): Pirmohamed M+, Pharmacogenetics 10(8), 705
(1999): Lehman DF+, J Clin Pharmacol 39, 533
(1999): Pakianathan MR+, AIDS 13, 1787
(1998): Mohanasundaram J+, J Indian Med Assoc 96, 21
(1998): Ryan C+, WMJ 97, 23
(1997): Hicks ME+, Ann Pharmacother 31, 1259
(1994): Carr A+, AIDS 8, 333
(1993): Marinac JS+, Clin Infect Dis 16, 178
(1993): Martin GJ+, Clin Infect Dis 16, 175
(1993): Mathelier-Fusade P+, Presse Med (French) 22, 1363
(1993): Mehta J+, J Assoc Physicians India 41, 235
Myalgia/Myositis/Myopathy/Myotoxicity
Pseudolymphoma
Rhabdomyolysis
(2006): Walker S+, Am J Med Sci 331(6), 339
(1998): Singer SJ+, Clin Infect Dis 26(1), 233
(1997): Anders HJ+, Eur J Med Res 2(5), 198
(1988): Arnold PA+, Drug Intell Clin Pharm 22, 43
Serum sickness (